PDB-code
Browse kinase entries (page 132 of 282)
First 128 129 130 PreviousLast136 135 134 Next| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File |
|---|---|---|---|---|---|---|---|---|---|---|
 | GSK3B | GSK | CMGC | 4ptc | B | A | 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide | Human | Show |  |
| GSK3B | GSK | CMGC | 4ptc | B | B | 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4pte | A | A | n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4pte | A | B | n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4pte | B | A | n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4pte | B | B | n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4ptg | A | A | 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4ptg | A | B | 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4ptg | B | A | 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 4ptg | B | B | 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 5f94 | A | A | 2-[(cyclopropylcarbonyl)amino]-n-(4-methoxypyridin-3-yl)pyridine-4-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 5f94 | A | B | 2-[(cyclopropylcarbonyl)amino]-n-(4-methoxypyridin-3-yl)pyridine-4-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 5f94 | B | A | 2-[(cyclopropylcarbonyl)amino]-n-(4-methoxypyridin-3-yl)pyridine-4-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 5f94 | B | B | 2-[(cyclopropylcarbonyl)amino]-n-(4-methoxypyridin-3-yl)pyridine-4-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 5f95 | A | 2-[(cyclopropylcarbonyl)amino]-n-(4-phenylpyridin-3-yl)pyridine-4-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 5f95 | B | 2-[(cyclopropylcarbonyl)amino]-n-(4-phenylpyridin-3-yl)pyridine-4-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 5hln | A | chir99021 | Human | Show | | |
| GSK3B | GSK | CMGC | 5hln | B | chir99021 | Human | Show | | |
| GSK3B | GSK | CMGC | 5hlp | A | A | 4-(2-methoxyphenyl)-3,7,7-trimethyl-1,6,7,8-tetrahydro-5h-pyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5hlp | A | B | 4-(2-methoxyphenyl)-3,7,7-trimethyl-1,6,7,8-tetrahydro-5h-pyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5hlp | B | A | 4-(2-methoxyphenyl)-3,7,7-trimethyl-1,6,7,8-tetrahydro-5h-pyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5hlp | B | B | 4-(2-methoxyphenyl)-3,7,7-trimethyl-1,6,7,8-tetrahydro-5h-pyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5k5n | A | 5-(3-chloranyl-4-methoxy-phenyl)-~{n}-[3-(1,2,4-triazol-1-yl)propyl]-1,3-oxazole-4-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 5k5n | B | 5-(3-chloranyl-4-methoxy-phenyl)-~{n}-[3-(1,2,4-triazol-1-yl)propyl]-1,3-oxazole-4-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 5kpk | A | (4~{s})-3-cyclopropyl-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | | |
| GSK3B | GSK | CMGC | 5kpk | B | (4~{s})-3-cyclopropyl-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | | |
| GSK3B | GSK | CMGC | 5kpl | A | A | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5kpl | A | B | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5kpl | B | A | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5kpl | B | B | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 5kpm | A | (4~{s})-3-(2,2-dimethylpropyl)-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | | |
| GSK3B | GSK | CMGC | 5kpm | B | (4~{s})-3-(2,2-dimethylpropyl)-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | | |
| GSK3B | GSK | CMGC | 5oy4 | A | ~{n}-[6-[3,4-bis(oxidanyl)phenyl]-1~{h}-pyrazolo[3,4-b]pyridin-3-yl]ethanamide | Human | Show | | |
| GSK3B | GSK | CMGC | 5oy4 | B | ~{n}-[6-[3,4-bis(oxidanyl)phenyl]-1~{h}-pyrazolo[3,4-b]pyridin-3-yl]ethanamide | Human | Show | | |
| GSK3B | GSK | CMGC | 5t31 | A | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | | |
| GSK3B | GSK | CMGC | 5t31 | B | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | | |
| GSK3B | GSK | CMGC | 6b8j | A | A | chir99021 | Human | Show | |
| GSK3B | GSK | CMGC | 6b8j | A | B | chir99021 | Human | Show | |
| GSK3B | GSK | CMGC | 6gjo | A | (3~{z})-5-ethanoyl-3-[[(1-methylpiperidin-4-yl)amino]-phenyl-methylidene]-1~{h}-indol-2-one | Human | Show | | |
| GSK3B | GSK | CMGC | 6gjo | B | (3~{z})-5-ethanoyl-3-[[(1-methylpiperidin-4-yl)amino]-phenyl-methylidene]-1~{h}-indol-2-one | Human | Show | | |
| GSK3B | GSK | CMGC | 6gn1 | A | ~{n}-[(~{e})-(6-bromanylimidazo[1,2-a]pyridin-3-yl)methylideneamino]-~{n},2-dimethyl-5-nitro-benzenesulfonamide | Human | Show | | |
| GSK3B | GSK | CMGC | 6gn1 | B | ~{n}-[(~{e})-(6-bromanylimidazo[1,2-a]pyridin-3-yl)methylideneamino]-~{n},2-dimethyl-5-nitro-benzenesulfonamide | Human | Show | | |
| GSK3B | GSK | CMGC | 6h0u | A | (2~{r})-3-[7-azanyl-5-(cyclohexylamino)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-2-yl]-2-cyano-propanamide | Human | Show | | |
| GSK3B | GSK | CMGC | 6h0u | B | (2~{r})-3-[7-azanyl-5-(cyclohexylamino)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-2-yl]-2-cyano-propanamide | Human | Show | | |
| GSK3B | GSK | CMGC | 6hk3 | A | A | 3-azanyl-~{n}-(2-methoxyphenyl)-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6hk3 | A | B | 3-azanyl-~{n}-(2-methoxyphenyl)-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6hk3 | B | A | 3-azanyl-~{n}-(2-methoxyphenyl)-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6hk3 | B | B | 3-azanyl-~{n}-(2-methoxyphenyl)-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6hk4 | A | A | 3-azanyl-6-(4-morpholin-4-ylsulfonylphenyl)-~{n}-pyridin-3-yl-pyrazine-2-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6hk4 | A | B | 3-azanyl-6-(4-morpholin-4-ylsulfonylphenyl)-~{n}-pyridin-3-yl-pyrazine-2-carboxamide | Human | Show | |
